Core to Evidence-Based Health Policy
cost-effectiveness evaluation for future healthcare
C2H is the only public research organization
for official cost-effectiveness evaluation process
in Japan

C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP).
Tools for cost-effectiveness evaluation
Latest news
-
news
New C2H Report: Valbenazine (Dysval)
Report of the cost-effectiveness evaluation on Valbenazine (Dysval) was released.
-
news
New C2H Report: Bimekizumab (Bimzelx)
Report of the cost-effectiveness evaluation on Bimekizumab (Bimzelx) was released.
-
news
New C2H Report: Andexanet alfa (Ondexxya)
Report of the cost-effectiveness evaluation on Andexanet alfa (Ondexxya) was released.